A special purpose acquisition company (SPAC) is a publicly listed shell company that raises capital through an IPO, holds the proceeds in a trust account, and then merges with or acquires a private operating business to take it public. The SPAC has no operations at IPO. Investors buy units, typically one common share plus a warrant or fraction, and most proceeds sit in trust until a deal closes or the SPAC liquidates. For finance professionals, SPACs matter because they offer an alternative path to public markets with different dilution mechanics, cash certainty risks, and governance trade-offs than traditional IPOs or direct listings. These differences show up directly in underwriting, deal structuring, covenant compliance, and portfolio risk.
A SPAC is not a blind-pool private equity fund. It is subject to securities law disclosure, stock exchange rules, shareholder approval, and redemption mechanics at the business combination. It is also not a reverse merger in the traditional sense, though the outcome can resemble one if target shareholders end up controlling the combined entity and the SPAC’s cash is minimal after redemptions.
Market terminology is loose. “De-SPAC” refers to the business combination. “PIPE” refers to private investment in public equity financing that often accompanies a de-SPAC to backstop redemptions or fund the purchase price. “Sponsor” refers to the SPAC founder entity that organizes the vehicle and receives founder shares and warrants as promote.
Three conditions must hold for a SPAC to succeed. The target must withstand public-company disclosure and reporting. Shareholders must approve the deal under applicable rules. Net cash delivered at close, after redemptions and transaction costs, must be adequate to fund the business plan and satisfy minimum cash conditions. If any fails, the SPAC liquidates and returns trust funds, and sponsor economics are usually wiped out.
The SPAC lifecycle starts with the sponsor forming the vehicle, contributing at-risk capital, and receiving founder shares and usually private placement warrants. That at-risk capital pays offering expenses and working capital, and it finances the private placement that occurs at IPO closing. Underwriters market units to public investors and the SPAC lists.
At IPO, the SPAC sells units consisting of one share of common stock and a warrant or fraction. A significant portion of gross IPO proceeds, net of underwriter discount, is deposited into a trust account intended to fund business combination consideration or redemption payments. Trust assets are usually invested in short-dated U.S. Treasury securities or qualifying money market funds. Interest may be used to pay taxes and, subject to disclosures, some expenses, though practices vary.
Trust protections are contractual rather than absolute. Vendors and potential targets are asked to sign waivers of claims against the trust, which reduces but does not eliminate leakage risk. Practitioners should treat trust leakage as a low-probability but high-severity scenario because it is hard to “model away” once it becomes real.
After IPO, the sponsor identifies a target. The process resembles an M&A transaction, but it runs inside public-company constraints such as managing material nonpublic information, insider trading controls, and disclosure timing.
Targets that are strong private IPO candidates may still choose a SPAC for negotiated pricing, a committed counterparty, or a bespoke capital structure. However, readiness risk is structural. If the target cannot produce PCAOB-quality audits and implement disclosure controls on a credible timeline, the de-SPAC will bleed time and credibility. In practice, the critical path usually runs through audits, pro formas, and SEC comment resolution rather than the headline valuation.
Once a business combination agreement is signed, the SPAC files a proxy statement or registration statement, depending on structure. The filing includes target financial statements, pro forma financials, risk factors, and transaction terms. The SEC review process can be significant, and timelines depend on comment cycles and the complexity of the target’s financial history.
Shareholder approval is required, and public shareholders can redeem regardless of how they vote. Redemptions are central to SPAC economics and cash certainty. They allow shareholders to take cash back at a per-share price approximately equal to their pro rata trust value. Because redemption levels can exceed expectations, a de-SPAC can close with materially less cash than the headline trust size.
The redeem-and-retain strategy has been common. Investors can redeem shares for cash and retain or sell warrants separately, depending on how units were split and trading history. This converts a “cash-like” position into an option-like payoff funded through dilution borne by the sponsor and non-redeeming shareholders.
For underwriting teams, this matters because your base case cannot assume the trust is committed capital. When redemptions spike, the entire capital plan often has to be rebuilt under time pressure. That is why many failures are not about valuation. They are about insufficient cash to fund the business plan and meet minimum cash conditions.
The SPAC structure embeds asymmetric incentives. Public shareholders have a redemption option that lets them convert shares back to near-cash at trust value while retaining warrants if they want. Sponsors hold founder shares that convert into meaningful equity at de-SPAC, creating a bias toward closing a deal even if quality is mediocre, because liquidation often means a near-total loss of at-risk capital and opportunity cost.
Targets use SPACs for speed and deal certainty relative to a traditional IPO, and for the ability to negotiate valuation and structure directly with a counterparty. Those benefits must be weighed against dilution from sponsor promote, warrants, underwriting and advisory fees, and PIPE pricing, plus the litigation and regulatory scrutiny that intensified after 2021.
Credit and private capital providers focus on cash certainty and the post-close capital structure. A de-SPAC can close with less cash than expected due to redemptions, forcing last-minute recapitalizations, covenant resets, and revised uses of proceeds. If you are underwriting credit risk, “trust size” is marketing. “net cash delivered” is reality.
PIPE financings supplement cash after redemptions, signal deal quality, and satisfy minimum cash conditions. PIPE investors negotiate price, registration rights, governance terms, and sometimes downside protection. In weaker markets, PIPE pricing can be discounted and structured with preferred equity, convertible instruments, or reset features that increase dilution.
Debt financing can also fund consideration or provide growth capital. Lenders focus on post-close leverage, liquidity, and whether PIPE proceeds are committed and conditioned. PIPE failure or repricing is a key risk, because PIPE investors may seek renegotiation if market conditions move, diligence findings change, or redemptions come in higher than expected.
In modelling terms, you should treat PIPE and debt as conditional sources until the closing conditions are tight and the timeline is credible. If you need a clean framework for scenario design, link the redemption cases to your stress testing and liquidity bridge rather than burying them in a footnote.
SPAC economics are driven by the sponsor promote, warrants, underwriting fees, and incremental financing costs. Sponsors typically receive founder shares at formation for nominal consideration, which convert into a meaningful equity stake at de-SPAC. Sponsors also buy private placement warrants, which provide additional upside and often have more favorable terms than public warrants.
Underwriting fees generally include an upfront component paid at IPO and a deferred component payable at de-SPAC closing. This aligns underwriters with completion, but it increases the cost burden on the de-SPAC. Legal, accounting, fairness opinion, and advisory fees also accumulate, and the target bears incremental public-company readiness costs.
Dilution is the primary structural critique of SPACs. Public warrants, sponsor promote, and PIPE discounts can reduce the value of common equity for long-term holders, and dilution is path-dependent. It worsens with high redemptions because fixed sponsor economics and many fixed costs are spread over fewer remaining public shares and less net cash.
A useful underwriting discipline is to convert all sponsor and warrant economics into an implied cost of capital per dollar of cash delivered at various redemption rates. If that implied cost is materially above alternatives, the SPAC starts to look like a financing of last resort, even if the headline valuation appears attractive. This is also where strong financial modelling discipline matters, because small differences in redemption assumptions can swing the effective price paid.
SPACs are public reporting companies from IPO onward, so their financial statements reflect cash, warrant liabilities or equity classification, and operating expenses. Warrant accounting has been a recurring issue. Depending on terms, warrants may be classified as liabilities and marked to fair value through earnings, creating P&L volatility that complicates investor messaging and valuation narratives.
Accounting for the de-SPAC depends on which entity is the accounting acquirer. Many de-SPACs are treated as reverse recapitalizations where the operating target is the accounting acquirer and the SPAC is the acquired shell. This affects historical financial statement continuity and can change how investors interpret growth versus “newco” adjustments.
Post-close, the combined company faces ongoing SEC reporting, internal control requirements, and audit scrutiny. Targets often underestimate the effort needed to sustain quarterly reporting, implement SOX-related controls, and manage guidance and disclosure controls. You should build these costs into the post-close operating model and liquidity forecast, especially if the investment thesis relies on tight cash burn management.
SPAC regulation tightened materially with SEC rulemaking finalized in 2024. The rules enhance disclosure requirements, address projections, and align aspects of de-SPAC liability with traditional IPO standards. Practically, that increases diligence, documentation rigor, and the cost and time to execute.
Governance expectations also rose because sponsor control and promote economics create conflicts that markets now price more aggressively through redemptions and discounts. Independent directors, audit committee quality, and conflicts management are not cosmetic. They influence whether the deal is financeable and whether the equity story survives the first few quarters as a public company.
SPAC risk becomes clear when you force the transaction into an investment committee format that cannot hide behind “trust value.” In an IC memo, the key question is not “what is the SPAC raising?” but “what cash arrives, what dilution buys that cash, and what runway remains after fees and readiness costs?”
This checklist also helps junior professionals. If you can explain, in one page, how net cash delivered changes under redemptions and how dilution moves the effective valuation, you will usually surface the real negotiation points earlier.
A traditional IPO typically provides primary capital with fewer embedded dilution features like warrants and sponsor promote, and it forces earlier market price discovery. SPACs can be faster in certain conditions, but post-2024 changes reduced the historical speed advantage and pushed process discipline closer to IPO standards. If you need a tighter comparison, see SPAC vs IPO framing on costs and outcomes.
A direct listing can provide liquidity without sponsor promote, but it may not deliver significant new money. Meanwhile, a private sale or minority private capital can deliver valuation certainty and avoid public-company burdens, at the cost of different control terms and a different cost of capital.
SPACs remain a viable tool, but finance professionals should underwrite them as a cash-and-dilution financing with embedded optionality, not as “trust-backed” certainty. If you start with net cash delivered under redemption stress, a dilution-adjusted valuation, and a credible public-company readiness plan, you will make better go or no-go calls and avoid deals that fail late, expensively, and publicly.
P.S. – Check out our Premium Resources for more valuable content and tools to help you break into the industry.
